Skip to main content
. Author manuscript; available in PMC: 2022 Nov 15.
Published in final edited form as: Cancer. 2021 Aug 10;127(22):4233–4239. doi: 10.1002/cncr.33831

Table 2.

Post-AHCT univariate outcomes

N = 360
Outcomes N Prob (95% CI)

Treatment related mortality 356
 100-day 1 (0–2)%
 1-year 3 (1–5)%
 2-year 6 (4–10)%
Relapse 356
 100-day 3 (2–5)%
 1-year 14 (10–17)%
 2-year 27 (22–33)%
Disease free survival 356
 100-day 96 (93–97)%
 1-year 84 (79–87)%
 2-year 66 (60–72)%
Overall survival 360
 100-day 98 (97–99)%
 1-year 94 (92–96)%
 2-year 83 (78–87)%